Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study

BACKGROUND: Combining trastuzumab and chemotherapy is standard in her2/neu overexpressing advanced breast cancer. It is not established however, whether trastuzumab treatment should continue after the failure of one earlier combination. In this trial, we report our experience with continued treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartsch, Rupert, Wenzel, Catharina, Hussian, Dagmar, Pluschnig, Ursula, Sevelda, Ursula, Koestler, Wolfgang, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1431554/
https://www.ncbi.nlm.nih.gov/pubmed/16539726
http://dx.doi.org/10.1186/1471-2407-6-63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1431554/
https://www.ncbi.nlm.nih.gov/pubmed/16539726
http://dx.doi.org/10.1186/1471-2407-6-63

Ejemplares similares